According to recently performed experiments, cannabis can be regarded as an effective solution for patients diagnosed with multiple sclerosis. While at first the symptomatic improvements experienced by individuals with multiple sclerosis who have been administered cannabinoid goods have been thought to be decided solely by psychological factors, eventually research has revealed that cannabis truly reduces muscular spasms as well as stiffness characteristic to multiple sclerosis patients. The benefic effects of cannabis on individuals with multiple sclerosis had been established by short term and long-term controlled medical studies.

In 2003, a group of researchers from the Peninsula Medical School in Exeter, UK have made public the results of a compilation of short-term and long-term studies on the consequences of cannabinoids among individuals with multiple sclerosis. The earlier conducted studies involved the active participation of around 600 individuals with advanced-stage multiple sclerosis. The people were divided in 2 distinctive groups: the first group got cannabinoid ingredients in the same doses, while the second group received placebo medications over a period of 15 days. By the end of the test, the vast majority of individuals who have been administered cannabinoids experienced a lot of symptomatic improvements, having less muscular pain and being confronted with gentler muscular spasticity (much less pronounced muscular spasm). Unlike the group that received cannabinoid compounds over the entire period of the study, the control group (patients who received placebo medications) skilled no improvements in their general condition.

To be able to confirm the relevancy of the results and to discard any uncertainties concerning the efficiency of cannabis within ameliorating the indications of several sclerosis, the analysis was later repeated. The ulterior analysis was performed over a period of twelve months, as well as involved the participation of the exact same subjects. However, this time the participants were divided into 3 distinctive groups rather than two as in the circumstances of the previous experiment. The first team received pills of D9-tetrahydrocannabinol (THC) – the active part of cannabis, the next group received natural cannabis extracts, while the last group received placebo medications.

At the conclusion of the experiment, patients had been very carefully evaluated as well as examined by a team of physiotherapists and neurologists. The best cbd for dogs with epilepsy; www.bellevuereporter.com, results have been obtained among the individuals belonging to the pioneer study group, the bulk of subjects that have received equal doses of THC having extensive improvements in the symptoms of theirs. The patients in the second study group encountered slight improvements in the symptoms of theirs, even though the patients in the final group sensed no changes in the condition of theirs.

Regardless of the fact these studies clearly suggest that cannabis is an efficient treatment for multiple sclerosis, medical experts aren’t still convinced that cannabinoids is successfully used in the treatment of several sclerosis. However, after performing more studies on the situation plus more elaborate research, doctors may consider to introduce cannabinoid compounds in the therapy of many sclerosis in the near future.

• 25/12/2021
• un messaggio di: Amore
• Da: tinabpe384